Targeting prostate cancer cell lines with polo-like kinase 1 innibitors as a single agent and in combination with histone deacetylase inhibitors

Author(s):
Wissing, M.D.; Mendonca, J.; Kortenhorst, M.S.Q.; Kaelber, N.S.; Gonzalez, M.; Kim, E.; Hammers, H.; Diest, P.J. van; Carducci, M.A.; Kachhap, S.K.
Published
2013
Publication type
Article / Letter to editor
Plk1HDACsynergymitotic kinasesspindle assembly checkpoint
Date issued
2013-10-31
Language
English
Is part of
FASEB Journal (2013), Vol. 27, no. 10, p. 4279-4293
hdl
1887/101361
doi
10.1096/fj.12-222893